Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy.
Pere DomingoMaría Gracia MateoJoan VillarroyaRubén CereijoFerràn TorresJoan Carles DomingoLaura CampderrósJosé M Gallego-EscuredoMaría Del Mar GutierrezIsabel MurNoemí CorbachoFrancesc VidalFrancesc VillarroyaMarta GiraltPublished in: Journal of clinical medicine (2022)
PLWH, especially when cART-treated, has increased GDF15 levels-this increase is associated with dyslipidemia, insulin resistance, metabolic syndrome, HALS, and inflammation-related parameters. GDF15 is unassociated with CVR when age-adjusted.
Keyphrases
- metabolic syndrome
- insulin resistance
- antiretroviral therapy
- hiv infected
- oxidative stress
- human immunodeficiency virus
- adipose tissue
- high fat diet
- hiv aids
- skeletal muscle
- hiv infected patients
- polycystic ovary syndrome
- cardiovascular disease
- cardiovascular risk factors
- high fat diet induced
- newly diagnosed
- hepatitis c virus
- south africa